NPI: 1750751491 · PHOENIX, AZ 85018 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/06/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 10/06/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,629 | $776K |
| 2019 | 15,259 | $572K |
| 2020 | 14,948 | $684K |
| 2021 | 13,397 | $650K |
| 2022 | 11,389 | $548K |
| 2023 | 8,697 | $544K |
| 2024 | 4,066 | $337K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 32,908 | 2,788 | $3.96M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 411 | 263 | $119K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 22,602 | 1,682 | $26K |
| J1270 | Injection, doxercalciferol, 1 mcg | 13,300 | 1,123 | $3K |
| 83970 | 232 | 203 | $696.49 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 175 | 150 | $476.84 |
| 82108 | 26 | 26 | $391.17 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 45 | 29 | $329.74 |
| 82728 | 171 | 148 | $220.01 | |
| 83550 | 95 | 74 | $140.41 | |
| 83540 | 176 | 148 | $104.63 | |
| 85041 | 460 | 388 | $51.00 | |
| 85048 | 432 | 363 | $43.12 | |
| A4657 | Syringe, with or without needle, each | 7,150 | 1,504 | $10.60 |
| J1756 | Injection, iron sucrose, 1 mg | 6,027 | 1,518 | $0.00 |
| 90674 | 79 | 74 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 96 | 92 | $0.00 |